Can you get pregnant with NMO?
An elevated rate of pregnancy complications in patients with NMO has been noted in several studies18,–20 (table 2). For example, of 85 pregnancies reported in 40 patients with NMOSD, 11 pregnancies (12.9%) in 6 participants were terminated by miscarriage (table 2).
Is Devic’s disease a form of MS?
Until recently, Devic’s disease was thought to be a kind of MS that caused more severe problems with the optic nerves and spinal cord. Recent research has suggested that Devic’s disease is probably a different disease in which there is a specific immune attack on a molecule known as aquaporin 4.
How long can you live with neuromyelitis optica?
About 1 in 3 people with untreated NMO die within 5 years of their first attack. Treatment dramatically improves these outcomes. When treated, the 5-year survival rate for monophasic (single attack) NMO is 90 percent. The survival rate for relapsing NMO (more than 1 attack) is nearly 70 percent when it is treated.
Is Devic’s disease hereditary?
NMO is usually not inherited, but some people with NMO may have a history of autoimmune disorders in the family and may have another autoimmune condition themselves.
Can NMO be monophasic?
Monophasic NMO Only about 5 to 10 percent of cases are monophasic. Monophasic means having a single attack. A single attack usually lasts 1 to 2 months but varies with each person. Men and women are equally likely to get this pattern of NMO.
Is Devic’s disease worse than MS?
With MS, changes in memory, reasoning, problem solving and depression are also common. Vision loss with MS usually affects one eye at a time, but Devic’s disease/NMO may affect both eyes at the same time. Symptoms are generally more severe for the Devic’s disease/NMO attack than the MS attack.
How long can you live with Devic’s disease?
NMO is also known as Devic’s disease or neuromyelitis optica spectrum disorder (NMOSD). Patients with neuromyelitis optica (NMO) patients have a 91% to 98% five-year survival rate. Current research indicates that neuromyelitis optica (NMO) patients have a 91% to 98% five-year survival rate.